1919 Investment Counsel’s AbbVie ABBV Stock Holding History

1919 Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$5.98M	Buy	103,531 +460	+0.4%	+$25.5K	0.12%	162
2014 Q2	$5.82M	Buy	103,071 +6,248	+6%	+$328K	0.12%	159
2014 Q1	$4.98M	Buy	96,823 +1,793	+2%	+$90.6K	0.1%	184
2013 Q4	$5.02M	Buy	95,030 +1,981	+2%	+$97.4K	0.1%	174
2013 Q3	$4.16M	Sell	93,049 -4,205	-4%	-$186K	0.09%	199
2013 Q2	$4.02M	Buy	+97,254	New	+$4.25M	0.09%	195

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

1919 Investment Counsel's ABBV Position: Q3 2014 in Review

1919 Investment Counsel increased its AbbVie (ABBV) stake by 0.45% in Q3 2014, buying an estimated $25.5K and bringing the position to 103,531 shares worth $5.98M. The position accounts for 0.12% of the portfolio, ranked #162.

1919 Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. 1,502 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

1919 Investment Counsel held 103,531 shares of AbbVie worth $5.98M as of Q3 2014.
1919 Investment Counsel bought 460 AbbVie shares in Q3 2014, an estimated $25.5K.
AbbVie made up 0.12% of 1919 Investment Counsel's portfolio in Q3 2014, its #162 holding.
1919 Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
1,502 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.